Abstract
We are grateful to the editors of Genome Medicine, who have rather incautiously invited us to write a monthly commentary on the exciting events that have occurred in this burgeoning field.We have decided to write the column together because one of us (DGN) is a clinical investigator and the other (SHO) is a basic geneticist and developmental biologist.Together, we believe we can do justice to the field and eschew cant.We begin with a discussion of the controversial role of genomewide association studies